Saifeng Pharmaceutical Technology

Saifeng Pharmaceutical Technology is a biotechnology company based in Suzhou, China, specializing in the development of mRNA therapeutics and advanced delivery systems. The company focuses on overcoming technical barriers in the mRNA field, particularly through its proprietary lipid nanoparticle (LNP) delivery technology and sequence optimization algorithms. Saifeng's research and development pipeline is primarily directed toward infectious disease vaccines, including COVID-19, and oncology treatments such as personalized cancer vaccines. By integrating sequence design, delivery vehicle engineering, and GMP-compliant manufacturing, the company aims to provide a comprehensive platform for nucleic acid medicine. Saifeng has attracted significant investment from prominent venture capital firms to accelerate its clinical programs and infrastructure development.